Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin for Retinopathy of Prematurity
NCT01232777Phase 2Withdrawn
- Sponsor
- Vision Research Foundation
- Start
- Jun 2012
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of bevacizumab in retinopathy of prematurity (ROP), sponsored by Vision Research Foundation. Planned start Jun 2012; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT01232777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01232777.